📈📈 Bullish Penny Stocks $1-$10 Range for the Week of 7.15.2019 💵💵 - #stockstowatch #pennystocks
What Is a Penny Stock: A penny stock refers to a small company's stock that typically trades for less than $5 per share. Although some penny stocks trade on large exchanges such as the New York Stock Exchange (NYSE), most penny stocks trade via over the counter (OTC) transactions. Transactions take place through the electronic OTC Bulletin Board (OTCBB) or through the privately-owned Pink Sheets. There is no trading floor for OTC transactions, and the quotations are also all done electronically.
The desire to make a quick killing in the stock market draws many inexperienced investors to trade in penny stocks. Unfortunately, this also means many people lose their money in the blink of an eye.
Why would anyone take on this type of risk? As the saying goes, “the higher the risk, the higher the potential returns.” If invested in the right companies, penny stocks can provide enormous returns. So if you’re comfortable with the risk versus return trade-off, and understand that you could lose your money, penny stocks could play a role in your portfolio.
What is Transparent Traders? ---> Read This...
Jonny Red's Penny Stock Trade Thoughts Below:
The below listed Penny Stock Tickers are all those that meet the criteria of the scanner. These are tickers that need to be watched and analyzed at Market Open to see if they will continue their Northern Momentum. I have posted a few of the charts for my favorite ones.
All of these tickers close today with 3 consecutive Green closes. I typically always look for penny's stock plays that have 2 to 3 consecutive GREEN days, and at least 800k+ in volume.
Transparent Traders Low Float Scanner for Penny Stocks http://tos.mx/OKvQSM
Borroow Some of My Stock Screeners: Click Here
See all Bullish Tickers below, but My Top Ticker Symbols are: WKHS - NGD - AFMD
- WKHS - I have been swing trading this since i bought in at 2.90, i believe it still has some room to move. I will watch Pre-Market and Open to see what happens but plan to continue holding for the time being. Looking for 3.80 minimum.
- NGD - I am looking for a slight pullback into the $1.10-$1.14 range and then Northern momentum to continue.
- AFMD - Slight pullback Monday and i am looking to enter around $3.05.
WKHS - Workhorse Group Inc. designs, manufactures, builds, sells, and leases battery-electric vehicles and aircraft in the United States. It operates through two divisions, Automotive and Aviation. The company also develops cloud-based and real-time telematics performance monitoring systems that enable fleet operators to optimize energy and route efficiency. Its products include electric cargo vans, and medium and light-duty pickup trucks, as well as HorseFly delivery drones systems. The company was formerly known as AMP Holding Inc. and changed its name to Workhorse Group Inc. in April 2015. Workhorse Group Inc. was founded in 2007 and is headquartered in Loveland, Ohio.
NGD - New Gold Inc., an intermediate gold mining company, engages in the development and operation of mineral properties. It primarily explores for gold, silver, and copper deposits. The company's operating properties include the Rainy River project located in Ontario, Canada; the New Afton project located near Kamloops, British Columbia, Canada; and the Cerro San Pedro mine located in the state of San Luis PotosÃ, Mexico. It also holds interests in the Blackwater project located to the Southwest of Prince George, British Columbia, Canada. The company was founded in 1980 and is headquartered in Toronto, Canada.
AFMD - Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Europe, and Germany. Its lead product candidate is AFM13, a natural killer cell (NK-cell) TandAb, which is in Phase 2a clinical study of relapsed CD30-positive lymphoma and Phase 1b clinical study of anti-PD-1 antibody Keytruda (pembrolizumab) in patients with relapsed Hodgkin lymphoma. The company's products include AFM24, an innate cell-engaging bispecific antibody that treats patients suffering of EGFR expressing solid tumors; AFM26, which binds to B cell maturation antigen (BCMA) for the treatment of multiple myeloma; and Trispecific Abs for the treatment of multiple myeloma. Its products also comprise AFM11, a T cell TandAb, which is in Phase 1 clinical trial in patients with relapsed CD19+ B cell malignancies, including non-Hodgkin Lymphoma and acute lymphocytic leukemia (AML); and AMV564, a CD33/CD3-specific T-cell TandAb is in Phase 1 clinical study of refractory AML. The company has license agreements with Amphivena Therapeutics, Inc., Deutsches Krebsforschungszentrum, and Xoma Ireland Limited; research funding agreement with The Leukemia & Lymphoma Society; and collaboration with Merck Sharp & Dohme B.V. It also has a clinical development and commercialization collaboration with The University of Texas MD Anderson Cancer Center to evaluate AFM13 in combination with MD Anderson's NK-cell product; and Genentech. The company was formerly known as Affimed Therapeutics B.V. and changed its name to Affimed N.V. in October 2014. Affimed N.V. was founded in 2000 and is headquartered in Heidelberg, Germany.
What Is a Penny Stock: A penny stock refers to a small company's stock that typically trades for less than $5 per share. Although some penny stocks trade on large exchanges such as the New York Stock Exchange (NYSE), most penny stocks trade via over the counter (OTC) transactions. Transactions take place through the electronic OTC Bulletin Board (OTCBB) or through the privately-owned Pink Sheets. There is no trading floor for OTC transactions, and the quotations are also all done electronically.
The desire to make a quick killing in the stock market draws many inexperienced investors to trade in penny stocks. Unfortunately, this also means many people lose their money in the blink of an eye.
Why would anyone take on this type of risk? As the saying goes, “the higher the risk, the higher the potential returns.” If invested in the right companies, penny stocks can provide enormous returns. So if you’re comfortable with the risk versus return trade-off, and understand that you could lose your money, penny stocks could play a role in your portfolio.
Jonny Red's Penny Stock Trade Thoughts Below:
All of these tickers close today with 3 consecutive Green closes. I typically always look for penny's stock plays that have 2 to 3 consecutive GREEN days, and at least 800k+ in volume.
- WKHS - I have been swing trading this since i bought in at 2.90, i believe it still has some room to move. I will watch Pre-Market and Open to see what happens but plan to continue holding for the time being. Looking for 3.80 minimum.
- NGD - I am looking for a slight pullback into the $1.10-$1.14 range and then Northern momentum to continue.
- AFMD - Slight pullback Monday and i am looking to enter around $3.05.
NGD - New Gold Inc., an intermediate gold mining company, engages in the development and operation of mineral properties. It primarily explores for gold, silver, and copper deposits. The company's operating properties include the Rainy River project located in Ontario, Canada; the New Afton project located near Kamloops, British Columbia, Canada; and the Cerro San Pedro mine located in the state of San Luis PotosÃ, Mexico. It also holds interests in the Blackwater project located to the Southwest of Prince George, British Columbia, Canada. The company was founded in 1980 and is headquartered in Toronto, Canada.
AFMD - Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Europe, and Germany. Its lead product candidate is AFM13, a natural killer cell (NK-cell) TandAb, which is in Phase 2a clinical study of relapsed CD30-positive lymphoma and Phase 1b clinical study of anti-PD-1 antibody Keytruda (pembrolizumab) in patients with relapsed Hodgkin lymphoma. The company's products include AFM24, an innate cell-engaging bispecific antibody that treats patients suffering of EGFR expressing solid tumors; AFM26, which binds to B cell maturation antigen (BCMA) for the treatment of multiple myeloma; and Trispecific Abs for the treatment of multiple myeloma. Its products also comprise AFM11, a T cell TandAb, which is in Phase 1 clinical trial in patients with relapsed CD19+ B cell malignancies, including non-Hodgkin Lymphoma and acute lymphocytic leukemia (AML); and AMV564, a CD33/CD3-specific T-cell TandAb is in Phase 1 clinical study of refractory AML. The company has license agreements with Amphivena Therapeutics, Inc., Deutsches Krebsforschungszentrum, and Xoma Ireland Limited; research funding agreement with The Leukemia & Lymphoma Society; and collaboration with Merck Sharp & Dohme B.V. It also has a clinical development and commercialization collaboration with The University of Texas MD Anderson Cancer Center to evaluate AFM13 in combination with MD Anderson's NK-cell product; and Genentech. The company was formerly known as Affimed Therapeutics B.V. and changed its name to Affimed N.V. in October 2014. Affimed N.V. was founded in 2000 and is headquartered in Heidelberg, Germany.
Post a Comment